Literature DB >> 34733074

High Rate of Inappropriate Fecal Immunochemical Testing at a Large Veterans Affairs Health Care System.

Adam B Gluskin1, Jeffrey M Dueker1, Asif Khalid1.   

Abstract

INTRODUCTION: Colonoscopies and fecal immunochemical tests (FITs) are the preferred modalities for colorectal cancer (CRC) screening. In addition to proper patient selection, appropriate fecal immunochemical testing requires that negative tests be repeated annually, positive tests lead to a diagnostic colonoscopy, and FIT not be performed within 5 years of a colonoscopy with adequate bowel preparation. We sought to study the frequency of inappropriate FITs at the Veterans Affairs Pittsburgh Health Care System in Pennsylvania.
METHODS: A retrospective quality assurance study was undertaken of veterans undergoing FIT in a 3-year period (2015-2017). We calculated the rate of a negative initial FIT in 2015/2016 followed by a second FIT in 2016/2017 in a random selection of veterans (3% SE, 95% CI). Demographics were compared in an equal random number of veterans that did and did not have a follow-up FIT (5% SE, 95% CI of all negative FIT). We also calculated the rate of completing colonoscopy following a positive FIT in a random selection of veterans (3% SE, 95% CI). Finally, we investigated use of FIT following a colonoscopy for all veterans in the study period.
RESULTS: A total of 6,766 FITs were performed; 4,391 unique veterans had at least 1 negative FIT, and 709 unique veterans had a positive FIT. Of 1,742 veterans with at least 1 negative FIT, 870 were eligible for repeat testing during the study period, and only 543 (62.4%) underwent at least 2 FITs. There was no significant demographic difference in veterans that had only 1 or at least 2 FITs. Of 410 veterans with a positive FIT, 113 (27.5%) did not undergo a subsequent colonoscopy within 1 year due to patient refusal, or failure to schedule or keep a colonoscopy appointment. Of 832 veterans who had both a FIT and colonoscopy in the interval, 108 veterans underwent colonoscopy with a subsequent FIT (1.6% of total FITs performed). Of these, 95 (88%) were judged to be inappropriate. Thirteen instances of FIT following colonoscopy were appropriate based on patient preference to undergo fecal immunochemical testing for CRC screening modality after undergoing colonoscopy with an inadequate bowel preparation.
CONCLUSIONS: Veterans underwent inappropriate testing due to failure to undergo serial FIT after a negative result (37.6%), failure to complete colonoscopy following a positive FIT (27.5%), and undergoing inappropriate FIT following a recent colonoscopy (88%). Efforts are still required to improve both patient and provider education and adherence to appropriate fecal immunochemical testing and CRC screening guidelines.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID: 34733074      PMCID: PMC8560050          DOI: 10.12788/fp.0142

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  12 in total

1.  Inappropriate colorectal cancer screening: findings and implications.

Authors:  Deborah A Fisher; Latisha Judd; Nadia S Sanford
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

2.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Authors:  Rachel B Issaka; Maneesh H Singh; Sachiko M Oshima; Victoria J Laleau; Carly D Rachocki; Ellen H Chen; Lukejohn W Day; Urmimala Sarkar; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

3.  Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

Authors:  Manon van der Vlugt; Esmée J Grobbee; Patrick M Bossuyt; Amanda C R K Bos; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Manon C W Spaander; Evelien Dekker
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-07       Impact factor: 11.382

4.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

5.  Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?

Authors:  Charlotte M Carlson; Katharine A Kirby; Michele A Casadei; Melissa R Partin; Christine E Kistler; Louise C Walter
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.

Authors:  Adam A Powell; Sameer D Saini; Matthew K Breitenstein; Siamak Noorbaloochi; Andrea Cutting; Deborah A Fisher; Hanna E Bloomfield; Krysten Halek; Melissa R Partin
Journal:  J Gen Intern Med       Date:  2015-01-21       Impact factor: 5.128

7.  Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.

Authors:  Ziad F Gellad; Daniel Almirall; Dawn Provenzale; Deborah A Fisher
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

8.  Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.

Authors:  Christopher D Jensen; Douglas A Corley; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Amy R Marks; Joanne E Schottinger; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Carrie N Klabunde; Charles P Quesenberry; Theodore R Levin; Pauline A Mysliwiec
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

9.  Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

Authors:  Douglas A Corley; Christopher D Jensen; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Joanne E Schottinger; Amy R Marks; Wei K Zhao; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Charles P Quesenberry; Bruce H Fireman; Theodore R Levin
Journal:  JAMA       Date:  2017-04-25       Impact factor: 56.272

10.  Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers.

Authors:  Yi-Chia Lee; Sam Li-Sheng Chen; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; Shu-Lin Chuang; Tsung-Hsien Chiang; Chu-Kuang Chou; Han-Mo Chiu; Ming-Shiang Wu; Chien-Yuan Wu; Shu-Li Chia; Shu-Ti Chiou; Hsiu-Hsi Chen
Journal:  J Natl Cancer Inst       Date:  2017-05-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.